Gout and Pseudogout: Practice Essentials, Background, Pathophysiology. Choi HK, Atkinson K, Karlson EW, et al. Alcohol intake and risk of incident gout in men: a prospective study. Apr 1. 7. 3. 63(9. Choi HK, Curhan G. Gout: epidemiology and lifestyle choices. Curr Opin Rheumatol. The gout patient in general practice. Rheumatol Rehabil. Martinon F, Glimcher LH. Gout: new insights into an old disease. J Clin Invest. 1. Gout in the spotlight. Arthritis Res Ther. The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort. Clin Rheumatol. 3. The Gout Diet. While there isn’t a regimented gout diet, anyone who is diagnosed with gout should follow a healthy, balanced diet. Avoid High Purine Foods. General practice geriatric medicine gynaecology infectious disease haematology: musculoskeletal medicine neurology obstetrics oncology ophthalmology paediatrics. Evidence Based Practice. PhD and reviewed by the American College of Rheumatology. Gout Family Practice Notebook. The diet must reduce. Fortunately gout prevention can soon spread to other joint gout family practice notebook. Gout (Podagra) Dr. Weyrich's Naturopathic Functional Medicine Notebook > Schedule a Consultation with Dr. Family history. Polynesian. Treatment- failure gout: a moving target. Arthritis Rheum. 5. Bluestone R, Waisman J, Klinenberg JR. The gouty kidney. Semin Arthritis Rheum. Ben Salem C, Slim R, Fathallah N, Hmouda H. Drug- induced hyperuricaemia and gout. Rheumatology (Oxford). Bleyer AJ, Hart TC. Genetic factors associated with gout and hyperuricemia. Adv Chronic Kidney Dis. Reginato AM, Mount DB, Yang I, Choi HK. The genetics of hyperuricaemia and gout. Nat Rev Rheumatol. Nature versus nurture in gout: a twin study. Liu- Bryan R, Scott P, Sydlaske A, et al. Innate immunity conferred by Toll- like receptors 2 and 4 and myeloid differentiation factor 8. Arthritis Rheum. 5. Nagase M, Baker DG, Schumacher HR Jr. Immunoglobulin G coating on crystals and ceramics enhances polymorphonuclear cell superoxide production: correlation with immunoglobulin G adsorbed. J Rheumatol. 1. 6(7): 9. Ortiz- Bravo E, Sieck MS, Schumacher HR Jr. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum. 3. Akahoshi T, Murakami Y, Kitasato H. Recent advances in crystal- induced acute inflammation. Curr Opin Rheumatol. Mechanisms of uric acid crystal- mediated autoinflammation. Immunol Rev. 2. 33(1): 2. Terkeltaub RA. What stops a gouty attack? J Rheumatol. Yagnik DR, Evans BJ, Florey O, et al. Macrophage release of transforming growth factor beta. Arthritis Rheum. 5. Recent developments in crystal- induced inflammation pathogenesis and management. Curr Rheumatol Rep. Richette P, Bardin T. Jan 2. 3. 3. 75(9. Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. Mc. Adams- Demarco MA, Maynard JW, Coresh J, Baer AN. Anemia and the onset of gout in a population- based cohort of adults: Atherosclerosis Risk in Communities study. Arthritis Res Ther. Aug 2. 0. Fructose- rich beverages and risk of gout in women. Nov 2. 4. 3. 04(2. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. Genome- wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Dehghan A, K. Association of three genetic loci with uric acid concentration and risk of gout: a genome- wide association study. Genome- wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 8. Meta- analysis of 2. Population heterogeneity in the genetic control of serum urate. Semin Nephrol. 3. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2. A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Campion EW, Glynn RJ, De. Labry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Hall AP, Barry PE, Dawber TR, Mc. Namara PM. Epidemiology of gout and hyperuricemia. A long- term population study. Lin HY, Rocher LL, Mc. Quillan MA, Schmaltz S, Palella TD, Fox IH. Cyclosporine- induced hyperuricemia and gout. N Engl J Med. 3. 21(5): 2. Rho YH, Zhu Y, Zhang Y, Reginato AM, Choi HK. Risk factors for pseudogout in the general population. Rheumatology (Oxford). Pseudogout attack induced during etidronate disodium therapy. Mod Rheumatol. 1. Taggarshe D, Ng CH, Molokwu C, Singh S. Acute pseudogout following contrast angiography. Clin Rheumatol. 2. Ciancio G, Bortoluzzi A, Govoni M. Epidemiology of gout and chondrocalcinosis. Jan 1. 9. 6. 3(4): 2. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2. Arthritis Rheum. 6. Kim KY, Ralph Schumacher H, Hunsche E, Wertheimer AI, Kong SX. A literature review of the epidemiology and treatment of acute gout. Terkeltaub RA. Gout: Recent advances and emerging therapies. Rheumatic Disease Clinics Update. Garg R, Sayles HR, Yu F, Michaud K, Singh J, Saag KG, et al. Gout- related health care utilization in US emergency departments, 2. Arthritis Care Res (Hoboken). Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z, et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol. 3. 5(9): 1. Cea Soriano L, Rothenbacher D, Choi HK, Garc. Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther. Epidemiology of gout and hyperuricaemia in Italy during the years 2. Ann Rheum Dis. 7. Reed D, Labarthe D, Stallones R. Epidemiologic studies of serum uric acid levels among Micronesians. Arthritis Rheum. 1. Jul- Aug. 1. 5(4): 3. Gout in Maoris. Semin Arthritis Rheum. Choi HK, De Vera MA, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford). Olaniyi- Leyimu BY. Consider gout in patients with risk factors, regardless of age. Am Fam Physician. Jul 1. 5. Fravel MA, Ernst ME. Management of gout in the older adult. Am J Geriatr Pharmacother. Singh H, Torralba KD. Therapeutic challenges in the management of gout in the elderly. Simmonds HA, Mc. Bride MB, Hatfield PJ, Graham R, Mc. Caskey J, Jackson M. Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol. 3. Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum. 3. Mody GM, Naidoo PD. Gout in South African blacks. Ann Rheum Dis. 4. Outcome evaluations in gout. J Rheumatol. 3. 4(6): 1. Becker MA, Mac. Donald PA, Hunt BJ, Lademacher C, Joseph- Ridge N. Determinants of the clinical outcomes of gout during the first year of urate- lowering therapy. Nucleosides Nucleotides Nucleic Acids. Changing trends of mortality in gout. Semin Arthritis Rheum. Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med. 2. Jan 2. 6. 1. 69(2): 1. Gout and mortality. Clin Exp Rheumatol. Sep- Oct. 2. 6(5 Suppl 5. S1. 15- 9. Lottmann K, Chen X, Sch. Association between gout and all- cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep. The role of uric acid in pediatric hypertension. Krishnan E, Svendsen K, Neaton JD, et al. Long- term cardiovascular mortality among middle- aged men with gout. Arch Intern Med. 2. May 2. 6. 1. 68(1. Kuo CF, See LC, Luo SF, Ko YS, Lin YS, Hwang JS, et al. Gout: an independent risk factor for all- cause and cardiovascular mortality. Rheumatology (Oxford). Gout Tied to Higher Risk of Heart Attack and Stroke. Medscape Medical News. Available at http: //www. Accessed: November 4, 2. Seminog OO, Goldacre MJ. Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies. Rheumatology (Oxford). Sep 1. 7. Gout Linked to Increased Vascular Disease Risk. Medscape Medical News. Available at http: //www. Accessed: September 8, 2. Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK Clinical Practice Research Datalink. Ann Rheum Dis. 2. Aug 2. 7. Chen JH, Lan JL, Cheng CF, Liang WM, Lin HY, Tsay GJ, et al. Effect of Urate- lowering Therapy on the Risk of Cardiovascular Disease and All- cause Mortality in Patients with Gout: A Case- matched Cohort Study. J Rheumatol. 4. 2 (9): 1. Solomon DH, Liu CC, Kuo IH, Zak A, Kim SC. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims. Ann Rheum Dis. 7. Cervical myelopathy induced by pseudogout in ligamentum flavum and retro- odontoid mass: a case report. Spinal Cord. 4. 4(1. Puig JG, Michan AD, Jimenez ML, et al. Female gout. Clinical spectrum and uric acid metabolism. Arch Intern Med. 1. Meyers OL, Monteagudo FS. Gout in females: an analysis of 9. Clin Exp Rheumatol. Apr- Jun. Macfarlane DG, Dieppe PA. Diuretic- induced gout in elderly women. Br J Rheumatol. 2. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1. Am J Kidney Dis. 4. Marchini GS, Sarkissian C, Tian D, Gebreselassie S, Monga M. Gout, stone composition and urinary stone risk: a matched case comparative study. Taniguchi Y, Yoshida M, Tamaki T. Posterior interosseous nerve syndrome due to pseudogout. J Hand Surg Br. 2. Dalbeth N, Schauer C, Macdonald P, Perez- Ruiz F, Schumacher HR, Hamburger S, et al. Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Ann Rheum Dis. 7. Stocker SL, Graham GG, Mc. Lachlan AJ, Williams KM, Day RO. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout. J Rheumatol. 3. 8(5): 9. Chehab MR, Goyal J, Schlesinger N. Tophaceous Pustule- like Rash in a Patient with Gout. J Rheumatol. 3. 9(1): 1. Coassin M, Piovanetti O, Stark WJ, Green WR. Urate deposition in the iris and anterior chamber. Ophthalmology. 1. Slansky HH, Kubara T. Intranuclear urate crystals in corneal epithelium. Arch Ophthalmol. 8. Bernad B, Narvaez J, Diaz- Torn. Clinical image: corneal tophus deposition in gout. Arthritis Rheum. MCWILLIAMS JR. Ocular findings in gout; report of a case of conjunctival tophi. Am J Ophthalmol. 3. Morris WR, Fleming JC. Gouty tophus at the lateral canthus.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2017
Categories |